Replies to post #87824 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

"For now, we suffer the paper loss"

Right, deteriorating from a $1 billion market cap to less than $20 million not even the value of cash on the balance sheet is just a paper loss. It reflects nothing fundamental about the company's clinical program or future. Keep telling yourself that.